Asymmetric dimethylarginine predicts decline of glucose tolerance in men with stable coronary artery disease: a 4.5-year follow-up study

Table 2 Cardiovascular drugs used during the follow-up period ^*

Drug class, n(%)	Deterioration in glucose tolerance (n = 24)	No deterioration in glucose tolerance (n = 56)	P value
Diuretics	6 (25%)	15 (27%)	0.87
β-blockers	19 (79%)	50 (89%)	0.23
α₁-blockers	5 (21%)	11 (20%)	0.91
Calcium channel blockers	10 (42%)	19 (34%)	0.51
Angiotensin receptor antagonists	2 (8%)	3 (5%)	0.61
Long-acting nitrates	9 (38%)	20 (36%)	0.88

^* Besides low-dose aspirin, angiotensin-converting enzyme inhibitors, statins and clopidogrel.

ISSN: 1475-2840